Evidence map›Paper›PMID 34830137›Full record

ArticleInternational journal of molecular sciences2021

Immunohistochemical Evaluation of Adaptor Protein FAM159B Expression in Normal and Neoplastic Human Tissues.

Anna-Sophia Lieselott Beyer, Daniel Kaemmerer, Jörg Sänger, Katja Evert, Amelie Lupp

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anna-Sophia Lieselott BeyerInstitute of Pharmacology and Toxicology, Jena University Hospital, 04474 Jena, Germany.
Daniel KaemmererDepartment of General and Visceral Surgery, Zentralklinik Bad Berka, 99438 Bad Berka, Germany.
Jörg SängerLaboratory of Pathology and Cytology Bad Berka, 99438 Bad Berka, Germany.
Katja EvertDepartment of Pathology, University of Regensburg, 93053 Regensburg, Germany.
Amelie LuppInstitute of Pharmacology and Toxicology, Jena University Hospital, 04474 Jena, Germany.ORCID 0000-0003-0141-7310
Jena University Hospital · DEZentralklinik Bad Berka · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FAM159B is a so-called adaptor protein. These proteins are essential components in numerous cell signalling pathways. However, little is known regarding FAM159B expression in normal and neoplastic human tissues. The commercially available rabbit polyclonal anti-human FAM159B antibody HPA011778 was initially characterised for its specificity using Western blot analyses and immunocytochemistry and then applied to a large series of formalin-fixed, paraffin-embedded normal and neoplastic human tissue samples. Confirmation of FAM159B's predicted size and antibody specificity was achieved in BON-1 cells, a neuroendocrine tumour cell line endogenously expressing FAM159B, using targeted siRNA. Immunocytochemical experiments additionally revealed cytoplasmic expression of the adaptor protein. Immunohistochemical staining detected FAM159B expression in neuronal and neuroendocrine tissues such as the cortex, the trigeminal ganglia, dorsal root and intestinal ganglia, the pancreatic islets and the neuroendocrine cells of the bronchopulmonary and gastrointestinal tract, but also in the syncytiotrophoblasts of the placenta. FAM159B was also expressed in many of the 28 tumour entities investigated, with high levels in medullary and anaplastic thyroid carcinomas, parathyroid adenomas, lung and ovarian carcinomas, lymphomas and neuroendocrine tumours of different origins. The antibody HPA011778 can act as a useful tool for basic research and identifying FAM159B expression in tissue samples.

Indexed as

Antibodies, MonoclonalAntibody SpecificityBiomarkers, TumorBlotting, WesternHumansImmunohistochemistryMembrane ProteinsNeoplasmsNeuroendocrine TumorsPrognosisReproducibility of ResultsSensitivity and SpecificityAntibodies, MonoclonalBiomarkers, TumorMembrane Proteinsadaptor proteinantibodyFAM159Bimmunohistochemistryneuroendocrinetumour

Identifiers

PMID34830137
PMCPMC8621455
OpenAlexW3212734701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.